Full-Time

Geriatric Medicine Assistant Attending

Geriatrics

Deadline 10/2/26
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

10,001+ employees

Cancer treatment, clinical research, and education

Compensation Overview

$260k - $385k/yr

New York, NY, USA

In Person

Category
Medical, Clinical & Veterinary (1)

Get referred to Memorial Sloan Kettering Cancer Center

See people who can refer or advise you

Requirements
  • Candidates must have superb clinical and interpersonal skills and familiarity with clinical research.
  • Candidates must be board certified or board eligible in geriatric medicine.
Responsibilities
  • Provide clinical service with a focus on geriatric patient care.
  • Improve quality of life before, during, and after treatment for patients aged 70 years and older.
  • Provide whole-body geriatric care, including mobility, mental health, and symptom management.
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

View

Memorial Sloan Kettering Cancer Center is a leading cancer care and research institution. It provides patient care through Memorial Hospital for Cancer and Allied Diseases and conducts research through the Sloan Kettering Institute, plus education programs. It treats cancer patients with a full range of services (consultations, therapies, and hospital care) and advances new treatments via clinical trials. Treatments and care are delivered by multidisciplinary teams guided by trial results from its research programs. MSK differentiates itself by its integrated model that combines clinical care, translational and basic cancer research, and education, supported by donations, grants, and partnerships with pharma and other research institutions. Its goal is to improve patient outcomes by expanding effective cancer therapies and prevention through rigorous research and high-quality patient care.

Company Size

10,001+

Company Stage

Grant

Total Funding

$90M

Headquarters

New York City, New York

Founded

1884

Get referred to Memorial Sloan Kettering Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 31, 2026 MSK won NCI, V Foundation, Gray Foundation, and St. Baldrick's funding.
  • MSK's digital pathology consortium with Yale and Tempus deepens data-network advantages.
  • New inpatient capacity supports complex referrals and protects market share through 2030.

What critics are saying

  • June 1, 2026 MSK sued GE HealthCare over PET/CT motion-correction patents.
  • May 1, 2026 and May 12, 2026 lawsuits target MSK labor and disability practices.
  • The $2.3 billion pavilion and research engine depend on philanthropy and reimbursement strength.

What makes Memorial Sloan Kettering Cancer Center unique

  • MSK combines world-class care, translational research, and first-in-human trials under one roof.
  • July 14, 2026 Akeso selected MSK for a U.S. gastric-cancer Phase II study.
  • June 2026 Griffin Pavilion adds 208 beds, 12 suites, and robotics infrastructure.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Company News

HealthTech HotSpot
Aug 5th, 2026
GRM Information Management and world-class Cancer research and treatment Center expand pathology and document storage relationship.

GRM Information Management and world-class Cancer research and treatment Center expand pathology and document storage relationship. JERSEY CITY, N.J.-(BUSINESS WIRE)-GRM Information Management and Memorial Sloan Kettering Cancer Center are proud to announce an expansion of their existing document and pathology storage relationship. The partnership was originally established in 2020, when GRM began providing storage services for a large portion of MSKCC's pathology blocks and slides that had previously been housed in the facilities of another storage vendor. After five years of delivering quality operations and service, MSKCC recently awarded GRM a multi-year contract that consolidated their entire document and pathology storage collection with GRM. This recent expansion adds tens of thousands of cubic feet of both pathology blocks and slides, as well as physical documents, and the ongoing management and delivery of them to MSKCC's research and clinical operations. GRM President & CEO, Avner Schneur, says, "GRM delivers first-class facilities, superior operations, and continues to define the gold standard for high-quality and consistent customer service." Schneur goes on to add, "And that's why industry-leading organizations like MSKCC are moving to us and consolidating their collections with us." GRM's climate-controlled storage facility, where MSKCC's pathology collection is housed, maintains physical standards and processes that are consistent with HIPAA, CLIA and CAP certification requirements. Additionally, GRM staff who handle and process pathology samples are highly trained and dedicated to servicing GRM's pathology clients. This dedicated segment of GRM's labor force possesses a high level of knowledge of clients and processes, which ultimately results in a nearly error-free environment and speed with processing requests and filling orders for pick-ups and deliveries. As a complement to GRM's high-touch, personal customer service, clients can also utilize GRM's eAccess online inventory management system and dashboard, which serves as the primary means for clients to view inventory and process delivery and pickup requests. The client's capability to request individual blocks and slides for pick-up and delivery is enabled by the barcoding of each sample, which virtually guarantees superior inventory management and traceability. GRM's blocks and slides storage business is a natural extension of GRM's core document storage offering, as well as the company's growing digital healthcare solutions and patient data management solutions. Counting many of the country's largest healthcare organizations as clients, GRM employs their secure cloud-based content services platform, VisualVault, to deliver a broad and growing set of digital data managements and workflow automation solutions that are powered by sophisticated data extraction technologies, robotic process automation (RPA), artificial intelligence (AI) and valuable analytics tools. GRM Information Management is a leading provider of document storage, pathology storage, scanning services and digital information management systems. GRM delivers its clients digital solutions in cooperation with VisualVault, its sister company and cloud-based ECM platform. Serving a diverse base of industries such as healthcare, government, legal, finance and human resources, GRM delivers its clients services such as digital conversion, advanced data capture solutions, document management systems, workflow automation, legacy data archiving, compliance and governance, business process management (BPM) and advanced analytics capabilities, as well as a full suite of document storage, scanning and physical records management services. GRM maintains offices in 15 major metros across the U.S., including Atlanta, Austin, Baltimore, Boston, Chicago, Dallas, Houston, Indianapolis, Los Angeles, Miami, New Jersey/New York, Philadelphia, San Antonio, San Francisco and Washington, D.C. GRM also has facilities in Lima, Peru; Rio de Janeiro, Sao Paulo, Brazil; and Bogota, Medellin and Cali, Colombia. For more information, visit GRM Information Management. August 5th, 2026 August 4th, 2026

Memorial Sloan Kettering Cancer Center
Aug 4th, 2026
Memorial Sloan Kettering Cancer Center ranked top Cancer Center in the Northeast and in New York metropolitan area, second in nation, and first in urology care by U.S News and World Report.

Memorial Sloan Kettering Cancer Center ranked top Cancer Center in the Northeast and in New York metropolitan area, second in nation, and first in urology care by U.S News and World Report. Tuesday, August 4, 2026 Memorial Sloan Kettering Cancer Center (MSK) has again been recognized among the nation's very best, earning the distinction as the top cancer center in the Northeast and in the New York metropolitan area, the #2 hospital for cancer care in the country, and the #1 hospital in the nation for urology care in the 2026-27 U.S. News & World Report Best Hospitals rankings. MSK has held its place among the nation's top two cancer hospitals and remained the leading cancer center in the Northeast since the rankings were established more than 35 years ago. "Being named the top cancer center in the Northeast and New York metropolitan area, and among the nation's leading cancer hospitals, is both an honor and a responsibility," said Selwyn M. Vickers, MD, FACS, President and CEO of MSK. "This recognition reflects the extraordinary people of MSK. Every day, our physicians, researchers, nurses, and staff advance cancer care with one goal in mind: improving the lives of patients and families. Together, we are working to end cancer for life." This latest recognition comes during a remarkable period of innovation and achievement. Over the past year, MSK earned national and global recognition for excellence in patient care, nursing, innovation, and workplace culture. In 2025, the U.S. Food and Drug Administration (FDA) approved 10 drugs based on clinical trials in which MSK played a pivotal role. Additionally, MSK earned its third Magnet(R) designation for nursing excellence and received Press Ganey's Guardian of Excellence Award for patient experience. MSK was also recognized by Forbes for the eighth consecutive year as one of America's Best Large Employers and as the nation's top cancer center to work for, and it was named one of Fast Company's Top 10 Best Workplaces for Innovators. For the fourth consecutive year, MSK secured USNWR's #1 national ranking in urology care, underscoring its leadership in the field. MSK's multidisciplinary urology team brings together experts in surgery, medical oncology, radiation oncology, radiology, pathology, and nursing to deliver highly personalized care while advancing innovative treatments that improve outcomes and preserve quality of life. In addition, MSK's gastroenterology and GI surgery services were ranked #25. The U.S. News & World Report rankings evaluate hospitals using a range of measures, including clinical outcomes, patient safety, nursing excellence, and reputation among board-certified physician specialists. Together, these honors underscore MSK's long-standing leadership in transforming cancer care and advancing hope for patients around the world.

Biological Relocation Solutions (BioRelo)
Jul 30th, 2026
NJ lab movers trusted by MSKCC and Sampled.

NJ lab movers trusted by MSKCC and Sampled. MSKCC and Sampled are leaders in biomedical research, biobanking, and life science operations. BioRelo supports their critical laboratory relocations with specialized planning, temperature control, and operational precision. As NJ lab movers, Biological Relocation Solutions, LLC help protect active laboratory operations during complex transitions. Its team manages temperature-sensitive materials, specialized equipment, and critical assets from pickup through final placement. This relocation covered less than 50 miles. However, laboratory moves are never defined by distance alone. Every sample, freezer, and piece of equipment represents years of scientific work. Each move requires careful planning and precise execution. Long-Standing partnership with Memorial Sloan Kettering Cancer Center. Memorial Sloan Kettering Cancer Center is one of the world's leading cancer research and treatment institutions. The organization advances patient care through groundbreaking research and scientific discovery. BioRelo has supported MSKCC through hundreds of laboratory relocations across multiple departments. Its team provides specialized transportation for biological materials, cold storage equipment, ultra-low temperature freezers, cryogenic storage systems, and complete laboratory moves. Biological Relocation Solutions, LLC understand the planning required for successful laboratory relocations. Its team helps minimize disruption while protecting valuable research assets. Years of scientific progress can exist inside a single freezer. That is why BioRelo prioritizes temperature control, communication, and careful execution throughout every move. The relationship BioRelo has built with MSKCC reflects its commitment to reliable laboratory relocation services. Biological Relocation Solutions, LLC act as an extension of each research team's operations. Supporting Sampled's biorepository and laboratory services. The destination for this relocation was Sampled, a globally recognized integrated analytical laboratory and biorepository headquartered in Piscataway, New Jersey. Sampled provides biobanking, analytical laboratory services, sample management, and logistics solutions that support pharmaceutical companies, biotechnology organizations, healthcare systems, and academic research institutions around the world. Among the organizations Sampled supports are Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, helping manage biospecimens and laboratory services that contribute to important research and clinical programs. Maintaining these collaborations requires dependable laboratory infrastructure and carefully coordinated logistics whenever laboratory equipment or biological materials must be relocated. BioRelo is proud to support Sampled by providing specialized laboratory moving services that help ensure critical research operations continue without interruption. Whether relocating loaded freezers, laboratory equipment, or temperature-sensitive biological materials, its team understands the importance of protecting every sample entrusted to its care. Laboratory relocation overview: MSKCC to Sampled. Project scope. * Origin: Memorial Sloan Kettering Cancer Center, New York * Destination: Sampled, Piscataway, New Jersey * Service: Temperature-controlled laboratory relocation * Materials: Biological samples, cold storage equipment, research assets * Distance: Less than 50 miles * Temperature Range: Ambient to -196°C Cold chain transport integrity. * Company-owned temperature-controlled vehicles * 24/7 temperature monitoring * Backup power systems * Redundant protection Northeast life science corridor. BioRelo's headquarters in Connecticut provides a strategic advantage when supporting laboratory relocations throughout the Northeast life science corridor, including New Jersey, New York, Massachusetts, and surrounding biotechnology hubs. Located within close proximity to many of the region's leading research institutions, pharmaceutical companies, hospitals, and biorepositories, its team is positioned to respond quickly while providing the specialized planning required for temperature-sensitive laboratory moves. For this relocation between Memorial Sloan Kettering Cancer Center and Sampled, its location allowed BioRelo to efficiently support both the origin and destination sites while maintaining the highest standards of cold chain protection. Being strategically located within the Northeast enables its team to provide responsive site coordination, streamlined logistics planning, and reliable support for organizations managing critical research assets. The Northeast continues to be one of the world's most concentrated life science regions, with leading academic institutions, healthcare systems, biotech companies, and pharmaceutical organizations relying on specialized laboratory infrastructure. BioRelo's presence in Connecticut places Biological Relocation Solutions, LLC at the center of this innovation corridor, allowing Biological Relocation Solutions, LLC to support complex laboratory relocations throughout New Jersey and beyond while acting as an extension of each research team's operations. Trusted NJ lab movers. As experienced NJ lab movers, BioRelo provides specialized laboratory relocation services for hospitals, biotechnology companies, pharmaceutical manufacturers, universities, biorepositories, and research organizations throughout the Northeast and across the United States. Its team safely transports biological materials, loaded ultra-low temperature freezers, laboratory refrigerators, cryogenic storage systems, laboratory equipment, and sensitive research assets from ambient conditions to -196°C using company-owned temperature-controlled vehicles equipped with continuous monitoring and redundant protection systems. Whether supporting long-standing partners like Memorial Sloan Kettering Cancer Center or organizations such as Sampled, BioRelo delivers the expertise, planning, and cold chain logistics laboratories rely on to protect valuable research. As trusted New Jersey lab movers, Biological Relocation Solutions, LLC remain committed to protecting scientific discoveries at every degree and every mile. Laboratory relocation services for life science organizations. Planning a laboratory relocation in New Jersey or relocating a laboratory to or from the state requires careful coordination, specialized equipment, and a team experienced in protecting sensitive materials, critical equipment, and operational workflows. Whether you need assistance with chemical inventory and packing, laboratory equipment preparation, ultra-low temperature freezer relocation, or transporting frozen biological samples without dry ice, BioRelo provides comprehensive laboratory moving services designed around the needs of today's life science organizations. Its team supports biotechnology companies, pharmaceutical organizations, healthcare systems, hospitals, universities, research institutions, diagnostic laboratories, biorepositories, and other specialized facilities with laboratory relocations throughout New Jersey, across the Northeast, and nationwide. From initial planning and inventory coordination to temperature-controlled transportation and final placement, BioRelo helps ensure your laboratory assets remain protected throughout every stage of the relocation process. If you are unsure where to begin with your laboratory relocation, BioRelo can help develop a customized plan based on your facility requirements, materials, timeline, and operational needs. Whether relocating one ultra-low temperature freezer or an entire laboratory, BioRelo provides the specialized support needed to protect valuable samples, equipment, and scientific operations from origin to destination.

HHC Weight Loss
Jul 28th, 2026
HHC names new Cancer Institute physician-in-chief.

HHC names new Cancer Institute physician-in-chief. July 28, 2026 Nationally recognized hematologic oncologist and physician executive Adam M. Boruchov, MD, will join Hartford HealthCare in July as physician-in-chief of the Hartford HealthCare Cancer Institute. Dr. Boruchov succeeds Peter Yu, MD, who is stepping down after more than a decade of leadership and will transition to the honorary role of physician-in-chief emeritus. Dr. Yu has played a pivotal role in building the Cancer Institute into a leading integrated cancer program known for clinical excellence, innovation and patient-centered care across Connecticut. In his emeritus role, Dr. Yu will continue advancing strategic oncology informatics initiatives in partnership with Hartford HealthCare leadership. Dr. Boruchov joins Hartford HealthCare from Northwell Health, formerly Nuvance Health, where he served as senior vice president and chair of the Cancer Institute. His career also includes leadership positions at Trinity Health of New England. He has extensive experience leading systemwide oncology strategy, expanding clinical research and trials, and developing high-performing cancer networks. Dr. Boruchov earned his bachelor's degree from Northwestern University and his medical degree from SUNY Downstate Medical Center, where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at New York Presbyterian Hospital and his hematology and oncology fellowship at Memorial Sloan Kettering Cancer Center, where he also held faculty and research appointments In his new role, Dr. Boruchov will focus on advancing innovation, strengthening physician leadership and further leveraging Hartford HealthCare's strategic partnership with Memorial Sloan Kettering Cancer Center to expand access to leading-edge cancer care statewide.

Associated Press
Jul 21st, 2026
TCG Digital partners with Memorial Sloan Kettering to commercialise AI-powered radiation oncology platform PlanQ

TCG Digital has licensed intellectual property from Memorial Sloan Kettering Cancer Center to develop and commercialise PlanQ, an AI-powered clinical intelligence platform for radiation oncology. The platform will be built on mcube, TCG Digital's Enterprise and Agentic AI Platform. PlanQ was developed by MSK's Department of Medical Physics to help radiotherapy teams coordinate through real-time integration and visualisation of patient treatment data. The system addresses fragmented clinical and operational systems that radiation oncology teams frequently navigate. The platform combines MSK's clinical expertise with TCG Digital's capabilities in AI, semantic technologies, and healthcare platform engineering. mcube integrates advanced AI, semantic intelligence, knowledge-driven reasoning, workflow automation, and scalable cloud architecture to support clinical decision-making in radiation oncology.